TRVI
Trevi Therapeutics Inc
12.80$
-2.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.7% | +8.3% | -7.7% | -8.3% | -27.3% | +12.5% | +66.7% | +26.7% | +78.9% | +2.9% | +0.0% | +0.0% | +8.6% | -5.3% | +5.6% | -2.6% | +2.7% | – | – | +9.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.9% | +45.5% | +9.0% | +20.7% | -26.2% | +65.6% | +2.2% | -14.6% | +24.8% | -18.2% | -1.9% | +35.9% | -14.8% | +16.3% | -27.4% | +31.0% | -24.8% | +9.9% | +13.1% | -25.2% | +15.8% | +16.8% | +8.2% | +3.1% | +35.1% | +13.8% | +12.0% | -16.9% | -16.3% | +20.2% | +7.4% | -38.6% | +60.5% | +52.4% | – | |
| – | +27.5% | +20.8% | +28.6% | +16.2% | +4.8% | +28.2% | +5.9% | -2.8% | +34.8% | -4.9% | -3.0% | +9.0% | -5.1% | +6.8% | -16.5% | -6.1% | +13.7% | +14.2% | -3.0% | -11.2% | +9.5% | -0.9% | +7.2% | -11.3% | +28.4% | +5.4% | -12.4% | +1.8% | +25.5% | +18.4% | -11.6% | +5.1% | +23.4% | +7.8% | – | |
| – | +40.8% | +39.4% | +13.2% | +19.6% | -18.8% | +54.1% | +3.1% | -11.6% | +27.7% | -14.2% | -2.3% | +26.9% | -12.0% | +13.3% | -24.2% | +19.1% | -15.1% | +11.3% | +7.5% | -20.8% | +13.6% | +10.8% | +7.9% | -1.6% | +33.4% | +11.6% | +6.3% | -13.4% | -6.0% | +19.6% | +1.4% | -26.6% | +45.9% | +37.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -36.9% | -58.5% | – | – | – | – | – | – | – | – | – | +108.1% | -4.5% | +0.7% | +2.4% | +2.0% | -2.3% | -2.3% | -1.0% | -6.2% | -15.7% | -34.6% | -98.0% | +33.3% | -75.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -188.2% | – | – | -400.0% | – | – | – | – | – | – | – | – | -144.4% | – | – | – | -168.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.